2CONTAG C H, JENKINS D, CONTAG P R, et al. Use of reporter genes for optical measurements of neoplastic disease in vivo [ J ]. Neoplasia,2000,2 ( 1-2 ) : 41-52.
3EDINGER M, CAO Y A, HORNIG Y S, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging [ J ]. Eur J Cancer,2002,38(16) : 2128-2136.
4CACERES G, ZANKINA R, ZHU X, et al. Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferasetransfected human tumors [ J ]. Anticancer Drugs, 2003,14 ( 7 ) : 569 -574.
5JENKINS D E, OEt Y, HORNIG Y S, et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis [ J ]. Clin Exp Metastasis, 2003, 20 ( 8 ) :733-744.
6SCATENA C D, HEPNER M A, OEI Y A, et al. Imaging of bioluminescent LNCaPluc-M6 tumors: a new animal model for the study of metastatic human prostate cancer[ J ]. Prostate, 2004,59 ( 3 ) : 292 -303.
7SCHEFFOLD C, KORNACKER M, SCHEFFOLD Y C, et al. Visualization of effective tumor targeting by CD8^+ natural killer T cells redirected with bispecific antibody F( ab' ) (2) HER2xCD3 [ J]. Cancer Res,2002,62(20) :5785-579|.
8ZEAMARI S, RUMPING G, FLOOT B, et al. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats[ J]. Br J Cancer,2004,90(6) : 1259-1264.
9LUKER G D, BARDILL J P, PRIOR J L, et al. Non-invasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice [ J ]. J Virol, 2002, 76 (23) : 12149- 12161.
10COOK S H, GRIFFIN D E. Luciferase imaging of a neurotropic viral infection in intact animals [ J ]. J Virol, 2003, 77 ( 9 ) :5333- 5338.
